Why Is Omnipod Insulin Device Maker Insulet Stock Jumping Today?
Why Is Omnipod Insulin Device Maker Insulet Stock Jumping Today?
Insulet Corporation (NASDAQ:PODD) shares are trading higher after the company reported preliminary second-quarter results.
Insulet 公司（納斯達克：PODD）的股票在公司發佈第二季度初步業績後上漲。
The company reported preliminary revenue of $488 million for the second quarter of 2024, marking a 23% increase from the $397 million reported in the previous year. The figure outpaces the street view of $460.27 million.
公司報告第二季度的初步營業收入爲4,8800萬美元，相比去年的3,9700萬美元增長了23%。該數字超過了街道預期的4,6027萬美元。
"Second quarter revenue exceeded our expectations across the board as a result of strong demand for Omnipod 5, resulting in robust revenue growth and sequential increases in new customer starts in both the U.S. and international markets," said Jim Hollingshead, President and Chief Executive Officer.
公司的總裁兼首席執行官Jim Hollingshead表示：“由於對Omnipod 5的強勁需求，美國和國際市場的新客戶增長情況持續提高，業績表現在第二季度全面超出了預期，營業收入強勁增長。”
This outperformance exceeds the guidance range of 15% to 18% in constant currency, driven by strong revenue growth across all product lines.
這種超預期的表現超過了通過所有產品線的強勁營收增長所驅動，且超出了15%至18%的常期匯率指引範圍。
Also Read: Walgreens Mulls Bond Sale As JPMorgan Gauges Investor Appetite: Report
此外閱讀：沃爾格林考慮發債，摩根大通評估投資者興趣：報告
Total Omnipod revenue reached $480 million, reflecting a 26% increase. In the U.S., Omnipod revenue was $352 million, up 27%.
總的來說，Omnipod營收達到了4,8000萬美元，同比增長了26%。在美國，Omnipod營收爲3,5200萬美元，增長了27%。
Internationally, Omnipod revenue totaled $128 million, marking a 23% increase, or 24% when adjusted for constant currency.
國際市場，Omnipod營收總額爲1,2800萬美元，同比增長23%，調整爲常期匯率後增長了24%。
Outlook Raised: When it releases its full financial results on August 8, 2024, the company expects to raise its full-year 2024 total Omnipod revenue outlook to 18% to 21% (previously 15% to 19%).
前景提高：2024年8月8日發佈全部財務業績後，公司預計將抬高2024年全年Omnipod總營收預期至18%至21%（之前爲15%至19%）。
Yesterday, Insulet's peer DexCom, Inc. (NASDAQ:DXCM) reported mixed second-quarter financial results and weak forward guidance.
昨天，Insulet的同業DexCom, Inc.（納斯達克：DXCM）報告第二季度財務業績不佳及弱勢前景。
Price Action: PODD shares are trading higher by 8.45% to $207.00 premarket at last check Friday.
股價表現：截至上週五盤前，PODD股價上漲8.45%，至207.00美元。
Photo via Company
照片來自公司
- Bill Ackman's US Fund IPO Target Slashed By 90% As Pershing Square 'Specifically Disclaims' CEO's Comments
- 彭宏基旗下基金目標IPO暴跌90%，Pershing Square”特別聲明”該公司CEO的評論無關緊要。